Related Blog Posts
Drug research updates-
23 hours ago ago from Pharmacy Education And Research .Com
Boehringer to announce trial results of female desire drug. Boehringer Ingelheim GmbH "is putting the finishing touches on a pill designed to reawaken desire by blunting female inhibitions." The company has been studying the drug compound, called Flibanserin, "for more than a decade and it has yet to publish clinical test results showing the drug is effective." It is said to announce data from trials of more than 5,000 European and US women ...
Related contentHeart transplant patients face higher risk of skin cancers
21 hours ago ago from Cancer News Today
Washington, Dec 25 (Inditop.com) Many heart transplant patients develop multiple skin cancers, says a new study. Solid organ transplant recipients are at
Related contentRelated News
Nothing to see... move along.
Related Videos
Nothing to see... move along.
